Biktarvy, formally known as biktarvy, is a powerful single-tablet regimen for controlling HIV infection. This drug combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the HIV's ability to replicate within the body, significantly lowering the viral burden. For many individuals,